Research conducted at the Lady Davis Institute provides proof of concept that an existing drug holds promise for reversing loss of memory and brain lesions associated with Alzheimer disease.
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials in humans against AD. These findings are published today in Nature Communications.
For years, Dr. Andréa LeBlanc, Senior Investigator at the LDI and Professor of Neurology and Neurosurgery at McGill University, has strived to identify early neurodegenerative events responsible for age-related memory loss. Her team discovered that the Caspase-6 enzyme is highly activated in Alzheimer disease brain lesions and associated with loss of memory. She, therefore, pursued the hypothesis that stopping Caspase-6 might provide relief from memory loss and stop progressive dementia. Since there are no specific Caspase-6 inhibitors, the LeBlanc team moved upstream, ultimately discovering that Caspase-1 was responsible for activating Caspase-6.
“This was a significant revelation because Caspase-1 inhibitors had been developed for treating inflammatory diseases,” explains Dr. LeBlanc. “Thus, we decided to test the effects of a particular Caspase-1 inhibitor, called VX-765, against memory loss and brain pathologies in a mouse model of Alzheimer disease.”
The work, first authored by Dr. Joseph Flores, a research associate in the LeBlanc lab, showed that VX-765 has an unprecedented beneficial effect in Alzheimer mice. The drug rapidly reverses memory loss, eliminates inflammation, and stops Alzheimer’s prototypical amyloid peptide accumulation in the mice brains. In addition to being safe for humans at relatively high doses for extended periods of time, it is capable of reaching the brain, a significant challenge in the development of drugs against disorders of the brain.
While Dr. LeBlanc cautions that there is a considerable bridge to cross between the mouse brain and that of a human, she believes that since her work has first identified the Caspase-1/Caspase-6 neurodegenerative pathway in human neurons and in human Alzheimer brains, there is a chance that this drug will work just as well in humans as it did in mice. Nevertheless, a clinical trial is needed to determine whether the drug will be beneficial against Alzheimer disease in humans.
Presently, there are no efficient treatments to significantly treat Alzheimer disease, the major affliction in a group of dementias that affect 47.5 million individuals worldwide.
The Latest on: Alzheimer’s
via Google News
The Latest on: Alzheimer’s
- Heroic PD Bryn finds missing man, 88, with Alzheimers after desperate call from concerned familyon October 6, 2020 at 6:38 am
Northamptonshire Police received a call from a worried family member of an 88-year-old man with Alzheimer’s to report him missing from an address in Northampton. Response officers, an armed response ...
- Walk To End Alzheimers in Daltonon October 5, 2020 at 6:46 am
CHATTANOOGA, Tenn. (WDEF)- Fire Prevention Week is this week and the Chattanooga fire department is "Serving Up Fire Safety in the Kitchen". CFD is "Serving ...
- Virtual marathon for Alzheimers patientson October 5, 2020 at 5:48 am
BLACKBURN Harriers runner completed the Virtual London Marathon for Alzheimers patients. Lindsay Davies works for Springfield Care Home in Blackburn and dedicated one mile to each person they had ...
- Alzheimers Q&A: How do relationships change through the Alzheimer’s disease journey?on October 5, 2020 at 3:18 am
Changes do occur in many aspects of relationships between the affected person and his or her caregiver during the course of the disease. These changes, however, do not diminish a person’s need ...
- Annual Walk to End Alzheimers Happens at Lincoln Parkon October 3, 2020 at 7:27 pm
GRAND JUNCTION, Colo. (KKCO) -People gathered nationwide on Saturday morning to walk and raise awareness for Alzheimers. The event usually has hundreds gather together to march, but this year it ...
- Parrot Heads raise nearly $2,700 for 'Walk to End Alzheimers'on September 29, 2020 at 10:32 am
Walk to End Alzheimer's, which is usually held in Fargo, looked a bit different this year due to the COVID-19 pandemic. Rather than holding a large event, organizers instead asked groups that ...
- Successful Walk to End Alzheimers may top $50,000 raisedon September 28, 2020 at 10:52 am
Nearly 400 walkers and teams from across the area participated in this year’s Walk to End Alzheimer’s in Kenosha and Racine counties.
- Alzheimers Q&A: How can I manage the feelings of loneliness in being an Alzheimer’s caregiver?on September 28, 2020 at 6:08 am
Most caregivers will experience feelings of loneliness to some degree in their Alzheimer’s caregiving journey. The isolation during this COVID-19 pandemic especially exacerbates these feelings, ...
- Care for the Alzheimers caregiver: A caregiver is who I amon September 27, 2020 at 11:29 am
Not too long ago, we were out and saw someone wearing a T-shirt that proclaimed the message: “Caregiver is not what I do, it’s who I am.” We were struck by both the simplicity of the wording ...
via Bing News